Association Between Schizophrenia and Cancer

This study has been completed.
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00419016
First received: January 4, 2007
Last updated: NA
Last verified: January 2007
History: No changes posted
  Purpose

A family study of the negative association betweeen schizophrenia and cancer


Condition
Schizophrenia
Cancer

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • schizophrenia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00419016

Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Gilad Gal, PhD The Gertner Institute for Epidemiology and Health Policy Research
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00419016     History of Changes
Other Study ID Numbers: SHEBA-06-4489-RG-CTIL
Study First Received: January 4, 2007
Last Updated: January 4, 2007
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia and Disorders with Psychotic Features
Mental Disorders

ClinicalTrials.gov processed this record on August 28, 2014